TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Syngene International Ltd. ( (IN:SYNGENE) ) is now available.
Syngene International Ltd. has confirmed its expansion of biologics capabilities by adding a new ADC bioconjugation facility. This development aims to offer comprehensive services for ADCs, from discovery to GMP manufacturing, enhancing the company’s operational efficiency and market competitiveness in the biopharmaceutical sector.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biopharmaceutical industry, providing integrated research, development, and manufacturing services. The company focuses on biologics, small molecules, and antibody-drug conjugates (ADCs), catering to global pharmaceutical and biotechnology companies.
Average Trading Volume: 40,265
Technical Sentiment Signal: Hold
Current Market Cap: 258.6B INR
See more insights into SYNGENE stock on TipRanks’ Stock Analysis page.